JP2023534803A5 - - Google Patents
Info
- Publication number
- JP2023534803A5 JP2023534803A5 JP2023502593A JP2023502593A JP2023534803A5 JP 2023534803 A5 JP2023534803 A5 JP 2023534803A5 JP 2023502593 A JP2023502593 A JP 2023502593A JP 2023502593 A JP2023502593 A JP 2023502593A JP 2023534803 A5 JP2023534803 A5 JP 2023534803A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimido
- pyridazin
- oxy
- dihydrobenzo
- dioxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052085P | 2020-07-15 | 2020-07-15 | |
| US63/052,085 | 2020-07-15 | ||
| PCT/US2021/041836 WO2022015988A1 (en) | 2020-07-15 | 2021-07-15 | 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534803A JP2023534803A (ja) | 2023-08-14 |
| JP2023534803A5 true JP2023534803A5 (https=) | 2024-07-17 |
| JP7766946B2 JP7766946B2 (ja) | 2025-11-11 |
Family
ID=77051222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502593A Active JP7766946B2 (ja) | 2020-07-15 | 2021-07-15 | ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US12331055B2 (https=) |
| EP (1) | EP4182316A1 (https=) |
| JP (1) | JP7766946B2 (https=) |
| KR (1) | KR20230039701A (https=) |
| CN (1) | CN116209446B (https=) |
| AU (1) | AU2021308625A1 (https=) |
| BR (1) | BR112023000760A2 (https=) |
| CA (1) | CA3189217A1 (https=) |
| IL (1) | IL299758B2 (https=) |
| MX (1) | MX2023000580A (https=) |
| WO (1) | WO2022015988A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7766946B2 (ja) * | 2020-07-15 | 2025-11-11 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 |
| WO2023114224A1 (en) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators |
| WO2023141511A1 (en) * | 2022-01-19 | 2023-07-27 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| WO2024117795A1 (ko) | 2022-12-02 | 2024-06-06 | 주식회사 엘지에너지솔루션 | 배터리 팩 및 그의 제조 방법 |
| AU2024259614A1 (en) | 2023-04-18 | 2025-10-02 | Vanderbilt University | Thiazolopyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| EP4731624A1 (en) * | 2023-06-22 | 2026-04-29 | Vanderbilt University | Positive modulators of the muscarinic acetylcholine receptor m4 |
| WO2025122733A1 (en) | 2023-12-07 | 2025-06-12 | Neumora Therapeutics, Inc. | Crystalline forms of 7-((2r,4s)-4-((2,3-dihydrobenzo[b][1,4] dioxin-6-yl-2,2,3,3-d4)oxy)-2-methylpiperidin-1-yl)-8-methyl-4h-pyrimido[1,2-b]pyridazin -4-one |
| WO2026047494A1 (en) | 2024-08-26 | 2026-03-05 | Suven Life Sciences Limited | 2-AMINO-PYRIMIDINE DERIVATIVES AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS (M4 PAMs) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9156833B2 (en) * | 2012-07-16 | 2015-10-13 | Barry University, Inc. | Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
| JP6478923B2 (ja) * | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| TW201726675A (zh) | 2015-12-23 | 2017-08-01 | 默沙東藥廠 | M4毒蕈鹼乙醯膽鹼受體之異位調節劑6,7-二氫-5h-吡咯并[3,4-b]吡啶-5-酮 |
| WO2017107087A1 (en) * | 2015-12-23 | 2017-06-29 | Merck Sharp & Dohme Corp. | 6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylcholine receptor |
| US10961253B2 (en) | 2016-11-07 | 2021-03-30 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| WO2018112843A1 (en) * | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2018112842A1 (en) * | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor |
| WO2018112840A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
| WO2019000238A1 (en) * | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR |
| JP7766946B2 (ja) * | 2020-07-15 | 2025-11-11 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 |
-
2021
- 2021-07-15 JP JP2023502593A patent/JP7766946B2/ja active Active
- 2021-07-15 WO PCT/US2021/041836 patent/WO2022015988A1/en not_active Ceased
- 2021-07-15 CN CN202180061237.9A patent/CN116209446B/zh active Active
- 2021-07-15 KR KR1020237005195A patent/KR20230039701A/ko not_active Withdrawn
- 2021-07-15 IL IL299758A patent/IL299758B2/en unknown
- 2021-07-15 EP EP21746304.1A patent/EP4182316A1/en active Pending
- 2021-07-15 US US18/005,301 patent/US12331055B2/en active Active
- 2021-07-15 AU AU2021308625A patent/AU2021308625A1/en active Pending
- 2021-07-15 CA CA3189217A patent/CA3189217A1/en active Pending
- 2021-07-15 MX MX2023000580A patent/MX2023000580A/es unknown
- 2021-07-15 BR BR112023000760A patent/BR112023000760A2/pt unknown
-
2023
- 2023-03-22 US US18/187,868 patent/US11884676B2/en active Active
-
2025
- 2025-05-09 US US19/203,407 patent/US20250263417A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023534803A5 (https=) | ||
| JP6839104B2 (ja) | ウイルス感染の治療及び予防のための新規な置換アミノチアゾロピリミジンジオン | |
| EP2991977B1 (en) | C-linked heterocycloalkyl substituted pyrimidines and their uses | |
| EP3489238B1 (en) | Pharmaceutical compositions of 6h-pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-one and [1,2,4]triazolo[1,5-c]pteridin-5(6h)-one derivatives as pde1 inhibitors for treating e.g. neurological disorders | |
| CN116209446B (zh) | 作为毒蕈碱性乙酰胆碱受体m4的正向别构调节剂的7-(哌啶-1-基)-4h-嘧啶并[1,2-b]哒嗪-4-酮衍生物 | |
| EP4248965A2 (en) | Compounds, compositions and methods | |
| JP2014521751A (ja) | 腎髄質外層カリウムチャンネルの阻害薬 | |
| CA2759399A1 (en) | Inhibitors of the renal outer medullary potassium channel | |
| JP2021520381A (ja) | 置換ピリジン及びピリミジン並びにｇｌｕｎ２ｂ受容体調節物質としてのそれらの使用 | |
| TW202220963A (zh) | 化合物、組合物及方法 | |
| EP3840832B1 (en) | Imidazo[1,2-b]pyridazines as trk inhibitors | |
| SK4712000A3 (en) | Halogen substituted tetracyclic tetrahydrofuran derivatives | |
| JP7432778B2 (ja) | 軟骨形成を誘導するための化合物及び組成物 | |
| CN114746414A (zh) | 氮杂-喹啉化合物及其用途 | |
| JP2017521399A (ja) | 腎髄質外層カリウムチャンネルの阻害剤 | |
| EP3402796A1 (en) | 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS | |
| CN108341819A (zh) | 磷酸二酯酶抑制剂及其用途 | |
| CN114075219B (zh) | 喹啉稠环类衍生物、其制备方法及其在医药上的应用 | |
| JP4580653B2 (ja) | 置換されたアミノイソオキサゾリン誘導体および抗鬱薬としてのそれらの使用 | |
| WO2010053825A1 (en) | 2-aminopyrimidine compounds as serotonin receptor modulators | |
| CN106065018B (zh) | 取代的吲哚化合物及其使用方法和用途 | |
| JP6787320B2 (ja) | テトラヒドロオキセピノピリジン化合物 | |
| WO2025252600A1 (en) | Activating compounds of potassium channels kv7.2/kv7.3 | |
| WO2025252599A1 (en) | Activating compounds of potassium channels kv7.2/kv7.3 | |
| HK40077297A (en) | Aza-quinoline compounds and uses thereof |